Sagent CEO: 'China Plant Producing and First Quarter Looks Strong' - Presented by: The Aol. On Network

Earnings visibility is difficult due to the multi-faceted nature of Sagent's generic drug business, however, CEO Jeffrey Yordon says he anticipates a strong first quarter after seeing sales rise 20 percent in Q4. He expects Sagent to launch between 12 and 16 new products this year after launching a dozen last year.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
RAD $ 6.717 0.33 ▼ 4.72%
SIRI $ 3.40 0.04 ▼ 1.16%
AAPL $ 98.825 1.15 ▲ 1.18%
FB $ 75.009 0.18 ▼ 0.24%
BAC $ 15.50 0.09 ▼ 0.58%
FDO $ 75.78 15.12 ▲ 24.93%
DLTR $ 56.05 1.83 ▲ 3.38%
GE $ 25.615 0.18 ▼ 0.68%

As of 7/28/2014, 02:24 PM
More Most Active